Valuation: Proto Script Pharmaceutical Corp.

Market Cap 1.97M 1.71M 1.59M 1.46M 2.76M 187M 2.81M 18.81M 7.37M 93.43M 7.38M 7.22M 308M P/E 2015 *
-
P/E 2016 -41.4x
Enterprise Value 2.01M 1.75M 1.63M 1.5M 2.83M 192M 2.88M 19.26M 7.54M 95.7M 7.56M 7.4M 316M EV / Sales 2015 *
-
EV / Sales 2016 394x
Free-Float
89.82%
Yield 2015 *
-
Yield 2016 -
1 week-50.00%
Current month-50.00%
1 month-50.00%
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0.02
10 years 0
Extreme 0
2.2
Manager TitleAgeSince
Chief Executive Officer 58 29/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-50.00%-.--%-80.00% 11.38K
-0.30%-3.30%-7.90%+64.22% 81.89B
+2.26%-3.55%+3.66%+80.42% 20.44B
+2.81%+2.58%-0.26%+8.84% 15.93B
+2.13%+4.36%+6.85%+13.32% 14.13B
0.00%+0.09%+26.68%+37.06% 12.07B
+1.65%+1.70%+24.52%+85.23% 7.7B
-0.84%-1.99%+53.23%+107.73% 6.95B
-0.03%+9.26%-17.25%-3.09% 5.96B
+1.34%+2.11%+19.96%-0.07% 5.39B
Average +0.90%+2.32%+10.95%+31.36% 17.05B
Weighted average by Cap. +0.65%+0.64%+2.38%+53.18%

Financials

2015 2016
Net sales 881K 766K 715K 657K 1.24M 84.02M 1.26M 8.43M 3.3M 41.9M 3.31M 3.24M 138M 789K 686K 640K 588K 1.11M 75.2M 1.13M 7.55M 2.96M 37.5M 2.96M 2.9M 124M
Net income -145K -126K -118K -108K -204K -13.84M -208K -1.39M -544K -6.9M -546K -533K -22.77M -7.18M -6.24M -5.83M -5.35M -10.09M -685M -10.26M -68.72M -26.91M -341M -26.98M -26.38M -1.13B
Net Debt 27.07K 23.53K 21.96K 20.16K 38.02K 2.58M 38.68K 259K 101K 1.29M 102K 99.42K 4.24M 47.78K 41.53K 38.77K 35.59K 67.11K 4.55M 68.28K 457K 179K 2.27M 179K 176K 7.49M
Logo Proto Script Pharmaceutical Corp.
Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.
Employees
13
  1. Stock Market
  2. Stocks
  3. PSCR Stock